Effects of lighting variability on locomotion in posterior cortical atrophy
Keir Yong, Dementia Research Centre, Box 16, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK.
E‐mail: ku.ca.lcu@gnoy.riek,
Abstract
Introduction
Clinical reports describe patients with Alzheimer's disease (AD) exhibiting atypical adaptive walking responses to the visual environment; however, there is limited empirical investigation of such behaviors or factors modulating their expression. We aim to evaluate effects of lighting‐based interventions and clinical presentation (visual‐ vs memory‐led) on walking function in participants with posterior cortical atrophy (PCA) and typical AD (tAD).
Methods
Participants with PCA (n = 10), tAD (n = 9), and healthy controls (n = 12) walked to visible target destinations under different lighting conditions within two pilot repeated‐measures design investigations (Experiment 1: 32 trials per participant; Experiment 2: 36 trials per participant). Participants walked to destinations with the floorpath interrupted by shadows varying in spatial extent (Experiment 1: no, medium, high shadow) or with different localized parts of the environment illuminated (Experiment 2: target, middle, or distractor illuminated). The primary study outcome for both experimental tasks was completion time; secondary kinematic outcomes were proportions of steps identified as outliers (Experiment 1) and walking path directness (Experiment 2).
Results
In Experiment 1, PCA participants overall demonstrated modest reductions in time taken to reach destinations when walking to destinations uninterrupted by shadows compared to high shadow conditions (7.1% reduction [95% confidence interval 2.5, 11.5; P = .003]). Experiment 2 found no evidence of differences in task performance for different localized lighting conditions in PCA participants overall. Neither experiment found evidence of differences in task performance between conditions in tAD or control participants overall. Completion time in both patient groups was longer relative to controls, and longer in PCA relative to tAD groups.
Discussion
Findings represent a quantitative characterization of a clinical phenomenon involving patients misperceiving shadows, implicating dementia‐related cortico‐visual impairments. Results contribute to evidence‐based design guidelines for dementia‐friendly environments.
Supporting information
Supporting Information.
Supporting Information.
Supporting Information.
Supporting Information.
Notes
Yong KXX, McCarthy ID, Poole T, et al. Effects of lighting variability on locomotion in posterior cortical atrophy. Alzheimer's Dement. 2020;6:e12077 10.1002/trc2.12077 [CrossRef] [Google Scholar]
References
- 1. Hussian RA, Brown DC. Use of two‐dimensional grid patterns to limit hazardous ambulation in demented patients. J Gerontol. 1987;42(5):558‐560. [[PubMed]
- 2. O'Malley M, Innes A, Wiener JM. Decreasing spatial disorientation in care‐home settings: how psychology can guide the development of dementia friendly design guidelines. Dementia. 2017;16(3):315‐328. [[PubMed]
- 3. Pai M‐C, Jacobs WJ. Topographical disorientation in community‐residing patients with Alzheimer's disease. Int J Geriatr Psychiatry. 2004;19(3):250‐255. [[PubMed]
- 4. Passini R, Pigot H, Rainville C, Tetreault M‐H. Wayfinding in a nursing home for advanced dementia of the Alzheimer's type. Environ Behav. 2000;32(5):684‐710. [PubMed]
- 5. Fleming R, Purandare N. Long‐term care for people with dementia: environmental design guidelines. Int Psychogeriatrics. 2010;22(7, SI):1084‐1096. [[PubMed]
- 6. Robinson L, Hutchings D, Corner L, et al. The effectiveness of non‐pharmacological interventions to prevent wandering in dementia. Health Technol Assessment. 2006;10(26). 10.3310/hta10260. [] [[PubMed]
- 7. Woodbridge R, Sullivan M, Harding E, et al. Use of the physical environment to support everyday activities for people with dementia: a systematic review. Dementia. 2016;17(5):533‐572.
- 8. Benson DF, Davis RJ, Snyder BD. Posterior cortical atrophy. Arch Neurol. 1988;45(7):789‐793. [[PubMed]
- 9. Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC. Posterior cortical atrophy. Lancet Neurol. 2012;11(2):170‐178.
- 10. McMonagle P, Deering F, Berliner Y, Kertesz A. The cognitive profile of posterior cortical atrophy. Neurology. 2006;66(3):331‐338. [[PubMed]
- 11. Tang‐Wai DF, Graff‐Radford NR, Boeve BF, et al. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology. 2004;63(7):1168‐1174. [[PubMed]
- 12. Warren JD, Fletcher PD, Golden HL. The paradox of syndromic diversity in Alzheimer disease. Nat Rev Neurol. 2012;8(8):451‐464. [[PubMed]
- 13. Lehmann M, Crutch SJ, Ridgway GR, et al. Cortical thickness and voxel‐based morphometry in posterior cortical atrophy and typical Alzheimer's disease. Neurobiol Aging. 2011;32(8):1466‐1476. [[PubMed]
- 14. Whitwell JL, Jack CR, Kantarci K, et al. Imaging correlates of posterior cortical atrophy. Neurobiol Aging. 2007;28(7):1051‐1061.
- 15. Mendez MF, Cherrier MM, Meadows RS. Depth perception in Alzheimer's disease. Percept Mot Skills. 1996;83(3):987‐995. [[PubMed]
- 16. Parasuraman R, Greenwood PM, Alexander GE. Alzheimer disease constricts the dynamic range of spatial attention in visual search. Neuropsychologia. 2000;38(8):1126‐1135. [[PubMed]
- 17. Mendola A, Cronin‐Golomb S, Corkin JG. Prevalence of visual deficits in Alzheimer's disease.pdf. Optom Vis Sci. 1995;72(3):155‐167. [[PubMed]
- 18. Yong KXX, Shakespeare TJ, Cash D, Henley SMD, Warren JD, Crutch SJ. (Con)text‐specific effects of visual dysfunction on reading in posterior cortical atrophy. Cortex. 2014;57:92‐106.
- 19. Shakespeare TJ, Crutch SJ, Fox NC. Posterior cortical atrophy: advice for diagnosis and implications for management. Neurodegener Dis Manag. 2012;2(6):599‐607. [PubMed]
- 20. Suárez‐González A, Henley SM, Walton J, Crutch SJ. Posterior cortical atrophy an atypical variant of Alzheimer disease. Psychiatr Clin N Am. 2015;38:211–220. [[PubMed]
- 21. Merrilees J, Barton C, Kuo A, Ketelle RComprehensive management of the patient with an atypical dementia Non‐Alzheimer's and Atypical Dementia. Chichester, UK: John Wiley & Sons, Ltd; 2016:202‐214. [PubMed][Google Scholar]
- 22. Morhardt D, Weintraub S, Khayum B, et al. The CARE pathway model for dementia: psychosocial and rehabilitative strategies for care in young‐onset dementias. Psychiatr Clin North Am. 2015;38(2):333‐352.
- 23. Bowes A, Dawson A, Greasley‐adams C, McCabe L. Developing best practice guidelines for designing living environments for people with dementia and sight loss. Ageing Soc. 2018;38(05):900‐925. [PubMed]
- 24. Jones GM, van der Eerden WJ. Designing care environments for persons with Alzheimer's disease: visuoperceptual considerations. Rev Clin Gerontol. 2008;18(01):13. [PubMed]
- 25. Tang‐Wai DF, Lake A, Graff‐Radford NR, Posterior cortical atrophy. Dementia : Comprehensive Principles and Practice. New York: Oxford University Press; 2014:666. [PubMed]
- 26. Yong ShakespeareTJ, Cash D, et al. Prominent effects and neural correlates of visual crowding in a neurodegenerative disease population. Brain. 2014;137(12):3284‐3299.
- 27. Shakespeare TJ, Pertzov Y, Yong KXX, Nicholas J, Crutch SJ. Reduced modulation of scanpaths in response to task demands in posterior cortical atrophy. Neuropsychologia. 2015;68:190‐200. [[PubMed]
- 28. Pantzartzis E, Price ADF, Pascale F. A built environment response to the rising costs of dementia. J Financ Manag Prop Constr. 2016;21(2):160‐187. [PubMed]
- 29. Torrington JM, Tregenza PR. Lighting for people with dementia. Light Res Technol. 2007;39(1):81‐97. [PubMed]
- 30. Utton . The design of housing for people with dementia. J Care Manag Serv. 2009;3(4):380‐390. [PubMed]
- 31. Evans N, Carey‐Smith B, Orpwood R. Using smart technology in an enabling way: a review of using technology to support daily life for a tenant with moderate dementia. Br J Occup Ther. 2011;74:249‐253. [PubMed]
- 32. Crutch SJ, Schott JM, Rabinovici GD, et al. Consensus classification of posterior cortical atrophy on behalf of the Alzheimer's Association ISTAART Atypical Alzheimer's Disease and Associated Syndromes Professional Interest Area. Alzheimer's Dement. 2017;13:870‐884.
- 33. Mendez MF, Ghajaraniad M, Perryman KM. Posterior cortical atrophy : clinical characteristics and differences compared to Alzheimer's disease. Dement Geriatr Cogn Disord. 2002;14:33‐40. [[PubMed]
- 34. McKhann GM, Knopman DS, Chertkow H, Hyman BT, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement. 2011;7(3):263‐269.
- 35. McCarthy I, Suzuki T, Holloway C, et al. Detection and localisation of hesitant steps in people with Alzheimer's disease navigating routes of varying complexity. Healthc Technol Lett. 2019;6(2):42‐47.
- 36. Benhamou S. How to reliably estimate the tortuosity of an animal's path—straightness, sinuosity, or fractal dimension?. J Theor Biol. 2004;229(2):209‐220. [[PubMed]
- 37. Yong KXX, McCarthy ID, Poole T, et al. Navigational cue effects in Alzheimer's disease and posterior cortical atrophy. Ann Clin Transl Neurol. 2018;5(6):697‐709.
- 38. Crane PK, Trittschuh E, Mukherjee S, et al. Incidence of cognitively defined late‐onset Alzheimer's dementia subgroups from a prospective cohort study for the Executive Prominent Alzheimer's Disease: genetics and Risk Factors (EPAD:gRF) Investigators. Alzheimer's Dement. 2017;13(12):1‐10.
- 39. Zhu L, Duval C, Boissy P, et al. Comparing GPS‐based community mobility measures with self‐report assessments in older adults with Parkinson's disease. J Gerontol A Biol Sci Med Sci. 2020. Jan 20;glaa012. 10.1093/gerona/glaa012. [] [[PubMed]
- 40. Feng C, Wang H, Lu N, Tu XM. Log transformation: application and interpretation in biomedical research. Stat Med. 2013;32(2):230‐239. [[PubMed]
- 41. Henry ML, Hubbard HI, Grasso SM, et al. Treatment for word retrieval in semantic and logopenic variants of primary progressive aphasia: immediate and long‐term outcomes. J Speech, Lang Hear Res. 2019;62(8):2723‐2749.
- 42. James M, Warrington EK, Plant GT, Thames Valley Test Company . Corvist : Cortical Vision Screening Test : Manual & Test Materials. Bury St. Edmunds, Suffolk, UK: Thames Valley Test Company; 2001. [PubMed]
- 43. Warrington EK, James M, Thames Valley Test Company . The Visual Object and Space Perception Battery. Bury St. Edmunds, Suffolk, UK: Thames Valley Test Company; 1991. [PubMed]
- 44. Warrington EK, The Camden Memory Test Battery. Brighton, UK: Psychology Press; 1996. [PubMed]